Cannara Biotech Inc. (TSX:LOVE)

Cannara Biotech Revenue

Cannara Biotech had revenue of 31.83M CAD in the quarter ending May 31, 2026, with 16.45% growth. This brings the company's revenue in the last twelve months to 117.45M, up 14.66% year-over-year. In the fiscal year ending August 31, 2025, Cannara Biotech had annual revenue of 107.32M with 30.64% growth.

• Revenue (ttm): 117.45M
• Revenue Growth: +14.66%
• P/S Ratio: 1.68
• Revenue / Employee: 259.59K
• Employees: 452
• Market Cap: 196.58M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Aug 31, 2025	107.32M	25.17M	30.64%
Aug 31, 2024	82.15M	24.59M	42.71%
Aug 31, 2023	57.56M	21.57M	59.91%
Aug 31, 2022	36.00M	18.73M	108.48%
Aug 31, 2021	17.27M	15.17M	723.42%
Aug 31, 2019	2.10M	-	-

Data Source: Fiscal.ai Last updated: Jul 15, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error